21 November 2022 - Myeloma New Zealand presented directly to PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) on Thursday, making ...
20 October 2022 - Patient engagement in health technology assessment has become increasingly important over the past 20 years. ...
4 August 2022 - The patient’s voice is increasingly important in securing access for therapies in markets and demonstrating how ...
1 August 2022 - Patients have a critical role in drug development, from identifying unmet medical needs to assessing meaningful ...
25 March 2022 - The FDA meets next week to review a closely watched drug for ALS, or Lou Gehrig’s ...
7 February 2022 - This project was implemented on behalf of the Health Technology Assessment Consumer Consultative Committee to explore training ...
4 February 2022 - Our objective was to analyse and review consumer comments in the PBAC's decision-making process. ...
19 October 2021 - PHARMAC is making changes to the way its advisory committees work to strengthen the input of ...
7 September 2021 - Consumer involvement in Australia’s medicines choices has been further strengthened under a new strategic agreement Medicines ...
3 August 2021 - The tectonic plates of healthcare technology assessment have shifted – but where does the patient voice ...
23 July 2021 - In the wake of last month’s controversial FDA approval of Biogen’s Aduhelm, Alzheimer’s Association CEO Harry ...
15 July 2021 - Health technology assessment agencies vary in their use of quantitative patient preference data and the extent to ...
6 July 2021 - The UK’s Medicines and Healthcare products Regulatory Agency has revealed its new delivery plan, outlining its ...
24 June 2021 - In a response letter to the ALS Association, the U.S. FDA has recognised the unmet therapeutic ...
24 June 2021 - It was an emotional evening among the nearly 200 in-person and online attendees at Parliament House last ...